Furthermore, EVs’ potential to deliver gene-editing tools opens new avenues for precise manipulation of gene expression in tauopathy models, which could be invaluable in unraveling the molecular mechanisms of tau aggregation and AD progression. Here, MAPT is linked to Alzheimer disease.